ResearchSpace
The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells
JavaScript is disabled for your browser. Some features of this site may not work without it.
- ResearchSpace
- →
- Research Publications/Outputs
- →
- Journal Articles
- →
- View Item
| dc.contributor.author |
Lugongolo, Masixole Y
|
|
| dc.contributor.author |
Manoto, Sello L
|
|
| dc.contributor.author |
Ombinda-Lemboumba, Saturnin
|
|
| dc.contributor.author |
Maaza, M
|
|
| dc.contributor.author |
Mthunzi-Kufa, Patience
|
|
| dc.date.accessioned | 2022-05-09T08:18:47Z | |
| dc.date.available | 2022-05-09T08:18:47Z | |
| dc.date.issued | 2020-06 | |
| dc.identifier.citation | Lugongolo, M.Y., Manoto, S.L., Ombinda-Lemboumba, S., Maaza, M. & Mthunzi-Kufa, P. 2020. The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells. <i>Biomedical Journal.</i> http://hdl.handle.net/10204/12405 | en_ZA |
| dc.identifier.issn | 2319-4170 | |
| dc.identifier.issn | 2320-2890 | |
| dc.identifier.uri | doi.org/10.1016/j.bj.2020.05.022 | |
| dc.identifier.uri | http://hdl.handle.net/10204/12405 | |
| dc.description.abstract | Human immunodeficiency virus (HIV) infection remains a global health challenge despite the use of antiretroviral therapy, which has led to a significant decline in the mortality rates. Owing to the unavailability of an effective treatment to completely eradicate the virus, researchers continue to explore new methods. Low level laser therapy (LLLT) has been widely used to treat different medical conditions and involves the exposure of cells or tissues to low levels of red and near infrared light. The study aimed to determine the effect of combining two unrelated therapies on HIV infection in TZM-bl cells. | en_US |
| dc.format | Fulltext | en_US |
| dc.language.iso | en | en_US |
| dc.relation.uri | https://www.sciencedirect.com/science/article/pii/S231941702030086X | en_US |
| dc.source | Biomedical Journal | en_US |
| dc.subject | Low level laser therapy | en_US |
| dc.subject | Human immunodeficiency virus | en_US |
| dc.subject | TZM-bl cells | en_US |
| dc.subject | Infected | en_US |
| dc.subject | Uninfected | en_US |
| dc.subject | Irradiation | en_US |
| dc.title | The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells | en_US |
| dc.type | Article | en_US |
| dc.description.pages | 11 | en_US |
| dc.description.note | This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). | en_US |
| dc.description.cluster | Manufacturing | en_US |
| dc.description.impactarea | Bio-photonics | en_US |
| dc.identifier.apacitation | Lugongolo, M. Y., Manoto, S. L., Ombinda-Lemboumba, S., Maaza, M., & Mthunzi-Kufa, P. (2020). The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells. <i>Biomedical Journal</i>, http://hdl.handle.net/10204/12405 | en_ZA |
| dc.identifier.chicagocitation | Lugongolo, Masixole Y, Sello L Manoto, Saturnin Ombinda-Lemboumba, M Maaza, and Patience Mthunzi-Kufa "The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells." <i>Biomedical Journal</i> (2020) http://hdl.handle.net/10204/12405 | en_ZA |
| dc.identifier.vancouvercitation | Lugongolo MY, Manoto SL, Ombinda-Lemboumba S, Maaza M, Mthunzi-Kufa P. The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells. Biomedical Journal. 2020; http://hdl.handle.net/10204/12405. | en_ZA |
| dc.identifier.ris | TY - Article AU - Lugongolo, Masixole Y AU - Manoto, Sello L AU - Ombinda-Lemboumba, Saturnin AU - Maaza, M AU - Mthunzi-Kufa, Patience AB - Human immunodeficiency virus (HIV) infection remains a global health challenge despite the use of antiretroviral therapy, which has led to a significant decline in the mortality rates. Owing to the unavailability of an effective treatment to completely eradicate the virus, researchers continue to explore new methods. Low level laser therapy (LLLT) has been widely used to treat different medical conditions and involves the exposure of cells or tissues to low levels of red and near infrared light. The study aimed to determine the effect of combining two unrelated therapies on HIV infection in TZM-bl cells. DA - 2020-06 DB - ResearchSpace DP - CSIR J1 - Biomedical Journal KW - Low level laser therapy KW - Human immunodeficiency virus KW - TZM-bl cells KW - Infected KW - Uninfected KW - Irradiation LK - https://researchspace.csir.co.za PY - 2020 SM - 2319-4170 SM - 2320-2890 T1 - The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells TI - The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells UR - http://hdl.handle.net/10204/12405 ER - | en_ZA |
| dc.identifier.worklist | 23711 | en_US |
